Clinical Trials Logo

Clinical Trial Summary

Caffeine is a widely used psychostimulant drug and acts as a competitive antagonist at adenosine receptors. Its effect is on neurons and glial cells of all brain areas. Chronic consumption of caffeine leads to tolerance which might be associated with an increased number of binding sites in the brain. In deep brain stimulation (DBS), the production of adenosine following the release of adenosine triphosphate (ATP) explains the reduction of in tremor. Binding of adenosine to adenosine A1 receptor suppresses excitatory transmission in the thalamus and thus reduces both tremor-and DBS-induced side effects. Also, the effect of adenosine was attenuated following the administration of the 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) adenosine A1 receptor antagonist. Therefore, the presence of a receptor antagonist such as caffeine was suggested to reduce the effectiveness of deep brain stimulation (DBS) in treating tremor and other movement disorders.

In light with this finding, we anticipate that the antagonistic effect of caffeine is a culprit to the reduction of effectiveness of any stimulation protocol in non-invasive stimulation (NIBS). In particular the excitatory effects of a NIBS protocol can tentatively be blocked in the presence of caffeine.

In this study, the effects of caffeine consumption on cortical excitability at the sensorimotor cortex shall be examined on focal and non-focal plasticity. Focal plasticity will be induced by paired associated stimulation (PAS) and global cortical plasticity from transcranial alternating current (tACS) stimulation. In case of tACS stimulation, 1) an excitatory protocol (tACS, 140 Hz, 1 mA) and 2) an inhibitory protocol (tACS, 140 Hz, 0.4 mA) with the active electrode over M1 and the return electrode over the orbitofrontal cortex will be used. Changes in cortical excitability are assessed using transcranial magnetic stimulation (TMS) recordings.

Research goals are to examine the effects of caffeine consumption on sensorimotor cortical excitability and stimulation induced plasticity. In addition, this study explores further factors which usually contribute to variability in cortical excitability studies. The results are expected to give a useful recommendation for researchers to reduce confounding factors and hereby improves repeatability.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03720665
Study type Interventional
Source University Medical Center Goettingen
Contact
Status Completed
Phase N/A
Start date October 1, 2018
Completion date November 18, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Recruiting NCT00789347 - Analysis of Cortical Excitability in Neuropathic Pain N/A
Completed NCT02168413 - Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation
Completed NCT04749745 - Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study Early Phase 1
Completed NCT04011670 - Neuroplastic Alterations of the Motor Cortex by Caffeine N/A
Withdrawn NCT03664206 - Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy
Completed NCT01740843 - The Effect of tDCS on Motor Performance and Cortical Excitability N/A
Completed NCT05206162 - TMS-EEG as a Tool to Study the Neuromodulatory Effects of Theta Burst Stimulation N/A
Completed NCT03627364 - Analisys of Cortical Excitability and Motor Function of Post Stroke Patients
Recruiting NCT05517954 - Cortical Excitability in Post-traumatic Epilepsy